The latest closing stock price for Humacyte as of September 19, 2024 is 5.45.
An investor who bought $1,000 worth of Humacyte stock at the IPO in 2020 would have $-436 today, roughly 0 times their original investment - a -13.36% compound annual growth rate over 4 years.
The all-time high Humacyte stock closing price was 16.99 on September 01, 2021.
The Humacyte 52-week high stock price is 9.97, which is 82.9% above the current share price.
The Humacyte 52-week low stock price is 1.96, which is 64% below the current share price.
The average Humacyte stock price for the last 52 weeks is 4.39.
An investor who bought $1,000 worth of Humacyte stock at the IPO in 2020 would have $-436 today, roughly 0 times their original investment - a -13.36% compound annual growth rate over 4 years.
The all-time high Humacyte stock closing price was 16.99 on September 01, 2021.
The Humacyte 52-week high stock price is 9.97, which is 82.9% above the current share price.
The Humacyte 52-week low stock price is 1.96, which is 64% below the current share price.
The average Humacyte stock price for the last 52 weeks is 4.39.